Zucker M J, Fuzesi L, Bausback-Aballo S, Shah S, Parsonnet V, Ribner H S
N J Med. 1993 Apr;90(4):292-4.
Heart transplantation is an effective treatment for end-stage congestive heart failure resulting in a one-year survival of 80 percent and a return to normal function in 90 percent of survivors. Refinements in the pre- and postoperative medical management of transplant recipients portend further benefits.
心脏移植是治疗终末期充血性心力衰竭的有效方法,患者一年生存率达80%,90%的存活者心脏功能恢复正常。移植受者术前和术后医疗管理的改进预示着会带来更多益处。